Trial Profile
Effect of liraglutide on vascular inflammation in type-2 diabetes: A randomized, placebo-controlled, double-blind, parallel clinical PET/CT trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIRAFLAME
- 01 Dec 2021 Results of secondary analysis assessing the treatment with liraglutide can reduce cardiac adipose tissue published in the Diabetes, Obesity and Metabolism
- 25 Sep 2020 Results presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 25 Sep 2020 Results of lipidomic analysis assessing lipid regulating effect of liraglutide presented at the 56th Annual Meeting of the European Association for the Study of Diabetes